Vogt-Koyanagi-Harada disease diagnostic criteria
Narsing A Rao1, Somsiri Sukavatcharin, Julie H Tsai
1The USC Doheny Eye Institute and the Department of Ophthalmology, Keck School of Medicine, University of Southern California, 1355 San Pablo Street, DVRC 211, Los Angeles, CA 90033, USA. nrao@usc.edu
Insights
Diagnostic criteria for Vogt-Koyanagi-Harada disease (VKH) were evaluated. The revised criteria showed 100% concurrence in early and late VKH phases, but prospective validation is needed.
Area of Science:
- Ophthalmology
- Immunology
- Neurology
Background:
- Vogt-Koyanagi-Harada (VKH) disease diagnosis relies on various proposed criteria.
- Key features include bilateral uveitis, meningismus, and extraocular changes.
- Cerebrospinal fluid pleocytosis is essential in some criteria but not others.
Purpose of the Study:
- To evaluate the revised diagnostic criteria for Vogt-Koyanagi-Harada disease.
- To assess the concurrence of revised criteria in early and late VKH phases.
Main Methods:
- Applied revised VKH diagnostic criteria to 28 early-phase and 88 late-phase VKH patients.
- Compared patient data against the First VKH International Workshop criteria.
Main Results:
- All 116 patients met the revised diagnostic criteria, showing 100% concurrence.
- The revised criteria demonstrated high applicability in both early and late VKH stages.
Conclusions:
- The revised diagnostic criteria for VKH are highly consistent in early and late disease phases.
- Prospective validation studies are essential to determine the positive and negative predictive values of all proposed VKH diagnostic criteria.
Abstract:
Several different sets of criteria have been proposed to establish the diagnosis of Vogt-Koyanagi-Harada disease (VKH). Various investigators have used the criteria proposed by Sugiura, those proposed by by the American Uveitis Society as well as the revised diagnostic criteria proposed by the First VKH International Workshop group. These three sets of criteria share several clinical features that are considered to be essential for establishing the diagnosis of VKH, including bilateral uveitis, meningismus, and other extraocular changes. The detection of cerebrospinal fluid pleocytosis is considered to be an absolute in the criteria proposed by Sugiura but is not required for the diagnosis of VKH by the revised diagnostic criteria. We applied the latter diagnostic criteria to 28 well-documented patients with early phase VKH and to 88 patients examined during the late phase of VKH. All of these early and late phase patients fulfilled the criteria of the revised diagnostic criteria proposed by the workshop group, indicating 100% concurrence. However, none of the above proposed criteria were prospectively validated to show the positive and negative predictive value of the proposed criteria. Such a prospective study should be undertaken to address the validity of any one or all of the above sets of VKH diagnostic criteria.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

